Anti-Diabetic Medications to Fight PD and LBD
Trial
Phase 4
Completed
Jan. 27, 2026
Heard about Parkinson’s Psychosis? Neither have I.
News
Parking Suns
Jan. 27, 2026
Turkish Adaptation of "Parkinson's Disease Quality of Life 7 (PDQoL7)" Questionnaire
Trial
N/A
Completed
Jan. 26, 2026
Effects of Exercise With Visual Feedback in Parkinson's Disease
Trial
N/A
Recruiting
Jan. 26, 2026
Comparing Biomarker-Guided DBS Programming With Standard Clinical Monopolar Programming
Trial
N/A
Not yet recruiting
Jan. 26, 2026
Examination of Factors Associated With Fatigue in Individuals Diagnosed With Parkinson's Disease
Trial
N/A
Completed
Jan. 26, 2026
Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using Neuroimaging
Trial
N/A
Recruiting
Jan. 26, 2026
Circuit-Based Deep Brain Stimulation for Parkinson's Disease P1A2&3 Catalyst
Trial
N/A
Recruiting
Jan. 25, 2026
Effects of Pallidal Deep Brain Stimulation Location on Motor Impairment in Parkinson's Disease
Trial
N/A
Recruiting
Jan. 25, 2026
MR-guided Focused Ultrasound Plus GCase
Trial
N/A
Recruiting
Jan. 22, 2026
Temporal trends and risk factors of hospital readmission following deep brain stimulation for Parkinson disease.
Research
Parkinsonism & related disorders
Jan. 22, 2026
Serum phosphorylated tau 217 in GBA1 variant carriers with and without Parkinson disease.
Research
Journal of Parkinson's disease
Jan. 22, 2026
Parkin Mutations and Their Functional Consequences
Trial
N/A
Completed
Jan. 21, 2026
Early Detection of Selected Neuropathologies in Motor Vehicle Drivers
Trial
N/A
Recruiting
Jan. 21, 2026
Attributional Style and Parkinson's Disease
Trial
N/A
Completed
Jan. 20, 2026
Voice-activated Intelligent Personal Assistant (VIPA) Intervention for People With Parkinson's Disease
Trial
N/A
Completed
Jan. 20, 2026
Fexofenadine as Adjuvant Therapy in Parkinson Disease
Trial
Phase 2
Recruiting
Jan. 20, 2026
GYKO-Based L-Test Reliability in Parkinson's Disease
Trial
N/A
Active, not recruiting
Jan. 20, 2026
A Study to Evaluate the Safety of Neural Stem Cells in Patients With Parkinson's Disease
Trial
Phase 1
Completed
Jan. 19, 2026
Comprehensive Assessment of Neurodegeneration and Dementia
Trial
N/A
Recruiting
Jan. 19, 2026